Key Documents
Janice Brown
Clinical Focus
-
Cancer
> Blood and Marrow Transplantation
- Blood and Marrow Transplantation
- Blood and Marrow Transplantation / Infectious Diseases
- Infectious Disease
Professional Education
-
SUMC - Graduate Medical Education
(1993) CA
-
SUMC - Graduate Medical Education
(1990) CA
-
SUMC - Graduate Medical Education
(1988) CA
-
University of Virginia
(1987) VA
-
BA, Stanford University
Biological Sciences (1981)
-
MD, University of Virginia
Hypoxemic myocardial injury (1987)
-
Residency, Stanford University
Internal Medicine (1990)
-
Fellowship, Stanford University
Infectious Diseases (1996)
Graduate & Fellowship Program Affiliations
Publications
-
Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation.
Vana ML,
Formankova D, Cha S, Sharma A, Potena L, Brown JM, Mocarski ES.
Clin Infect Dis.
2008;
47
(4):
535-9
-
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation.
Nguyen VH,
Shashidhar S, Chang DS, Ho L, Kambham N, Bachmann M, Brown JM, Negrin RS.
Blood.
2008;
111
(2):
945-53
-
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.
Wloch MK,
Smith LR, Boutsaboualoy S, Reyes L, Han C, Kehler J, Smith HD, Selk L, Nakamura R, Brown JM, Marbury T, Wald A, Rolland A, Kaslow D, Evans T, Boeckh M.
J Infect Dis.
2008;
197
(12):
1634-42
-
Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination.
Noda S,
Aguirre SA, Bitmansour A, Brown JM, Sparer TE, Huang J, Mocarski ES.
Blood.
2006;
107
(1):
30-8
-
Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature.
Cha S,
Johnston L, Natkunam Y, Brown J.
Transpl Infect Dis.
2005 Sep-Dec;
7
(3-4):
158-61
-
Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia.
BitMansour A,
Cao TM, Chao S, Shashidhar S, Brown JM.
Blood.
2005;
105
(9):
3535-7
-
Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus.
García-Ojeda ME,
Dejbakhsh-Jones S, Chatterjea-Matthes D, Mukhopadhyay A, BitMansour A, Weissman IL, Brown JM, Strober S.
J Immunol.
2005;
175
(7):
4363-73
-
Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted.
Arber C,
Bitmansour A, Shashidhar S, Wang S, Tseng B, Brown JM.
J Infect Dis.
2005;
192
(9):
1666-71
-
Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
Dvorak CC,
Steinbach WJ, Brown JM, Agarwal R.
Bone Marrow Transplant.
2005;
36
(7):
621-9
-
The influence of the conditions of hematopoietic cell transplantation on infectious complications.
Brown JM,
Curr Opin Infect Dis.
2005;
18
(4):
346-51
-
Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective.
Brown JM,
Curr Opin Infect Dis.
2005;
18
(4):
352-8
-
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.
Johnston LJ,
Brown J, Shizuru JA, Stockerl-Goldstein KE, Stuart MJ, Blume KG, Negrin RS, Chao NJ.
Biol Blood Marrow Transplant.
2005;
11
(1):
47-55
-
Fungal infections in bone marrow transplant patients.
Brown JM,
Curr Opin Infect Dis.
2004;
17
(4):
347-52
-
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation.
Arber C,
BitMansour A, Sparer TE, Higgins JP, Mocarski ES, Weissman IL, Shizuru JA, Brown JM.
Blood.
2003;
102
(2):
421-8
-
Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation.
BitMansour A,
Brown JM.
J Infect Dis.
2002;
186
(1):
134-7
-
Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation.
BitMansour A,
Burns SM, Traver D, Akashi K, Contag CH, Weissman IL, Brown JM.
Blood.
2002;
100
(13):
4660-7
-
Immunity to infections following hematopoietic cell transplantation.
Brown JM,
Weissman IL, Shizuru JA.
Curr Opin Immunol.
2001;
13
(4):
451-7
-
Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome.
Mocarski ES,
Prichard MN, Tan CS, Brown JM.
Virology.
1997;
239
(1):
169-75
-
Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice.
Brown JM,
Kaneshima H, Mocarski ES.
J Infect Dis.
1995;
171
(6):
1599-603
-
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene.
Greaves RF,
Brown JM, Vieira J, Mocarski ES.
J Gen Virol.
1995;
76 ( Pt 9)
2151-60